Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02475850 · ClinicalTrials.gov registry record · Phase 3
Strategies to Reduce Injuries and Develop Confidence in Elders
A Phase 3 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 5,451
- Enrollment target
NCT02475850: Completed Phase 3 study, sponsored by Brigham and Women's Hospital.
NCT02475850 is a Phase 3 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 5,451 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (606% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02475850, a Phase 3 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 5,451 participants
- Enrollment target
Study Summary
The aim of this pragmatic cluster-randomized trial is to determine the effectiveness of an evidence-based, patient-centered multifactorial fall injury prevention strategy in community dwelling older adults at risk of falls recruited from 86 primary care practices around the U.S.
Primary Outcome
Number of first adjudicated serious fall-related injury serious fall-related injury events per 100 per years of follow-up.
Interventions
- OTHER Usual care
- OTHER Evidence-based tailored fall prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,451 participants |
| Start Date | 2015-08 |
| Est. Completion | 2020-01 |
| Phase | Phase 3 |
What the finished NCT02475850 record still lists
NCT02475850 is an interventional study that assigns participants to a tested intervention. Its 5,451 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (606% higher).
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT02475850 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02475850 about?
NCT02475850 is a clinical study titled "Strategies to Reduce Injuries and Develop Confidence in Elders". The aim of this pragmatic cluster-randomized trial is to determine the effectiveness of an evidence-based, patient-centered multifactorial fall injury prevention strategy in community dwelling older adults at risk of falls recruited from 86 primary care practices around the U.S.
What is the current status of trial NCT02475850?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 5,451 participants. The study started on 2015-08. Estimated completion is 2020-01.
What interventions are being tested in trial NCT02475850?
The interventions under investigation include: Usual care (OTHER), Evidence-based tailored fall prevention (OTHER).
Who is sponsoring clinical trial NCT02475850?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02475850's enrollment target sits among peer trials
5,451 45th of 2000 higher than 1,956 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
- NCT05722769 · 5,408 participants · NA
CSTOP Now! Child Sex Trafficking Stops With You
- NCT05952557 · 5,500 participants · Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- NCT06084234 · 5,500 participants · Phase 4
National Liver Cancer Screening Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia